You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 298 No. 2, July 11, 2007 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Commentary
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (7)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Drug Therapy, Other
 •Health Policy
 •Alert me on articles by topic

Relevance of Cost-effectiveness Analysis to Clinicians and Policy Makers

Allan S. Detsky, MD, PhD, FRCPC; Andreas Laupacis, MD, MSc, FRCPC

JAMA. 2007;298:221-224.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

One of the main objectives of educating clinicians and policy makers is to help them make better decisions. Should I order blood cultures for this patient? Can this patient with chest pain safely go home or should she be admitted to the hospital? Do I recommend implementing a hospital-wide influenza immunization program for all patients and health care workers? Should my hospital buy a new information technology system?

Most clinicians and health care administrators like to think these decisions are based on the rational use of all relevant information. The traditional patient-physician relationship of 50 years ago required that the physician base his or her recommendation on the clinical risks and benefits of each option. Costs were considered only if the patient bore them directly. Health care is now much more expensive, and a variety of insurance schemes pay . . . [Full Text of this Article]

What Is a Cost-effectiveness Analysis?

Author Affiliations: Departments of Health Policy, Management, and Evaluation, and Medicine, University of Toronto (Drs Detsky and Laupacis), Departments of Medicine, Mount Sinai Hospital and University Health Network (Dr Detsky), Keenan Research Centre at the Li Ka Shing Knowledge Institute of St Michael's Hospital (Drs Detsky and Laupacis), Toronto, Ontario, Canada.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The concept of prevention: a good idea gone astray?
Starfield et al.
J. Epidemiol. Community Health 2008;62:580-583.
ABSTRACT | FULL TEXT  

Willingness to Pay for a Cure in Patients with Chronic Gout
Khanna et al.
Med Decis Making 2008;28:606-613.
ABSTRACT  

A Framework for Health Care Organizations to Develop and Evaluate a Safety Scorecard
Pronovost et al.
JAMA 2007;298:2063-2065.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.